T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gen Digital
GEN
|
+$2.03B |
| 2 |
DuPont de Nemours
DD
|
+$1.83B |
| 3 |
Crown Castle
CCI
|
+$1.58B |
| 4 |
Microsoft
MSFT
|
+$1.48B |
| 5 |
TransUnion
TRU
|
+$781M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DD
Du Pont De Nemours E I
DD
|
+$1.72B |
| 2 |
Starbucks
SBUX
|
+$1.59B |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
+$1.3B |
| 4 |
Lowe's Companies
LOW
|
+$1.13B |
| 5 |
Philip Morris
PM
|
+$1.01B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.97% |
| 2 | Financials | 16.84% |
| 3 | Technology | 15.92% |
| 4 | Consumer Discretionary | 13.45% |
| 5 | Industrials | 10.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1351
iRhythm Holdings
IRTC
$4.06B
| $8.87M | ﹤0.01% |
170,932
-7,020
| -4% | -$318K |
|
1352
Aclaris Therapeutics
ACRS
$863M
| $8.78M | ﹤0.01% |
340,343
-67,400
| -17% | -$1.81M |
|
1353
Copa Holdings
CPA
$6.14B
| $8.7M | ﹤0.01% |
69,861
-4,762
| -6% | -$602K |
|
|
MDSO
1354
DELISTED
Medidata Solutions, Inc.
MDSO
| $8.66M | ﹤0.01% |
110,958
-300
| -0.3% | -$22.8K |
|
1355
Travere Therapeutics
TVTX
$5.79B
| $8.63M | ﹤0.01% |
346,701
+1,907
| +0.6% | +$42K |
|
1356
Sally Beauty Holdings
SBH
$1.55B
| $8.63M | ﹤0.01% |
440,533
+19,710
| +5% | +$387K |
|
|
FL
1357
DELISTED
Foot Locker
FL
| $8.54M | ﹤0.01% |
242,576
+1,906
| +0.8% | +$80.2K |
|
1358
Materion
MTRN
$5.9B
| $8.52M | ﹤0.01% |
197,497
+184,537
| +1,424% | +$7.07M |
|
1359
argenx
ARGX
$54.8B
| $8.42M | ﹤0.01% |
375,137
-7,653
| -2% | -$160K |
|
|
NETS
1360
DELISTED
Netshoes (Cayman) Limited
NETS
| $8.38M | ﹤0.01% |
637,182
-710,039
| -53% | -$11.5M |
|
1361
MGE Energy Inc
MGEE
$3.06B
| $8.36M | ﹤0.01% |
129,359
+109,810
| +562% | +$7.1M |
|
1362
ON Semiconductor
ON
$31.8B
| $8.31M | ﹤0.01% |
449,700
+16,062
| +4% | +$258K |
|
|
CTWS
1363
DELISTED
Connecticut Water Service Inc
CTWS
| $8.3M | ﹤0.01% |
139,942
+101,910
| +268% | +$5.73M |
|
1364
CAE Inc. Common Shares
CAE
$8.9B
| $8.28M | ﹤0.01% |
+474,300
| New | +$8M |
|
1365
Navient
NAVI
$867M
| $8.25M | ﹤0.01% |
549,043
+5,200
| +1% | +$75.8K |
|
|
ABAX
1366
DELISTED
Abaxis Inc
ABAX
| $8.1M | ﹤0.01% |
181,420
+12,262
| +7% | +$583K |
|
1367
Royal Gold
RGLD
$19.1B
| $8.08M | ﹤0.01% |
93,936
-74,461
| -44% | -$6.45M |
|
|
MXIM
1368
DELISTED
Maxim Integrated Products
MXIM
| $7.98M | ﹤0.01% |
167,267
+634
| +0.4% | +$29.1K |
|
|
SRT
1369
DELISTED
Startek Inc.
SRT
| $7.92M | ﹤0.01% |
673,963
-528,660
| -44% | -$6.4M |
|
1370
Markel Group
MKL
$22.8B
| $7.91M | ﹤0.01% |
7,404
+1
| +0% | +$1.03K |
|
|
TAHO
1371
DELISTED
Tahoe Resources Inc
TAHO
| $7.9M | ﹤0.01% |
1,505,647
-601,930
| -29% | -$3.28M |
|
1372
Olin
OLN
$2.13B
| $7.82M | ﹤0.01% |
228,197
+171,923
| +306% | +$5.36M |
|
|
EFOR
1373
Everforth Inc
EFOR
$1.34B
| $7.81M | ﹤0.01% |
145,509
+104,515
| +255% | +$5.23M |
|
1374
Williams-Sonoma
WSM
$28.9B
| $7.79M | ﹤0.01% |
312,632
-120,738
| -28% | -$2.81M |
|
1375
lululemon athletica
LULU
$13.6B
| $7.77M | ﹤0.01% |
124,872
+16,656
| +15% | +$1M |
|
Similar funds
T. Rowe Price Associates's Q3 2017 Portfolio in Review
As of Q3 2017, T. Rowe Price Associates held 2,642 positions worth $585B, up 5.3% from $556B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
T. Rowe Price Associates's Q3 2017 filing shows 88 new, 1,025 increased, 900 reduced and 73 closed positions. Its largest new stake was Brighthouse Financial: 4,532,679 shares worth $276M. The largest sale was Du Pont De Nemours E I, an estimated $1.72B.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 18% a quarter earlier, followed by Financials and Technology.
- T. Rowe Price Associates's largest Q3 2017 buy was Brighthouse Financial: 4,532,679 shares worth $276M.
- T. Rowe Price Associates added most to Gen Digital in Q3 2017, an estimated $2.03B increase.
- T. Rowe Price Associates's biggest Q3 2017 reduction was Starbucks, cutting an estimated $1.59B.
- T. Rowe Price Associates fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $1.72B.
- T. Rowe Price Associates's ten largest holdings make up 18% of its $585B portfolio in Q3 2017.
- T. Rowe Price Associates opened 88 new positions and closed 73 in Q3 2017.
- T. Rowe Price Associates's portfolio value rose 5.3% quarter-over-quarter to $585B.
Based on T. Rowe Price Associates's 13F filing for Q3 2017, filed 14 Nov 2017.